About the Authors

Synne Torkildsen

Affiliations Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Hematology, Oslo University Hospital, Oslo, Norway

Ludmila Gorunova

Affiliations Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Klaus Beiske

Affiliation Department of Pathology, Oslo University Hospital, Oslo, Norway

Geir E. Tjønnfjord

Affiliations Department of Hematology, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway

Sverre Heim

Affiliations Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Institute of Clinical Medicine, Medical Faculty, University of Oslo, Oslo, Norway

Ioannis Panagopoulos

ioannis.panagopoulos@rr-research.no

Affiliations Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: ST IP. Performed the experiments: ST LG IP. Analyzed the data: ST LG SH IP. Contributed reagents/materials/analysis tools: ST KB GET SH. Wrote the paper: ST SH IP. Hematological data on the AML patient: ST KB GET.